Cerberus lines up €500m Bayer unit

Cerberus Capital Management, the US turnaround specialist, is reported to be in exclusive talks to buy German drug giant Bayer’s blood products unit for over €500 million.

ByPEI Staff

30 December 2012•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Cerberus lines up €500m Bayer unit

Cerberus Capital Management

Bain Capital

Related articles